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ABSTRACT 
 
This study investigates the secondary metabolites of 
an endophytic Aspergillus sp. isolated from leaves 
of M. oleifera growing in Anambra State, South-
Eastern Nigeria. Antimicrobial and antioxidant 
screening of the fungal extract and isolated 
compounds, as well as cytotoxicity assay of the 
extract against cisplatin-sensitive A2780 (sens) and 
cisplatin-resistant A2780 (cisR) ovarian cancer cell 
lines were carried out using standard methods. 
Chemical investigations of the fungal extract 
involving a combination of different chromato-
graphic methods and spectroscopic techniques          
were carried out to isolate and characterize the 
constituents of the extract. At a concentration range 
of 1-4 mg/ml, the crude extract of Aspergillus sp. 
showed mild antimicrobial activity against Bacillus 
subtilis, Klebsiella pneumoniae, and Candida 
albicans. The fungal extract showed good anti-
oxidant activity at 500 µg/ml, with an inhibition of 
72.1%. Also, at 100 µg/ml, the extract showed 
excellent cytotoxic activity against A2780 (sens) 
and A2780 (cisR), with growth inhibitions of 
105.1% and 105.5% respectively. Two known 
pharmacologically active phenolic compounds              
(p-hydroxyphenyl acetic acid and ferulic acid) were 
isolated from the fermentation extract of the 
endophytic fungus. At 250 µg/ml, ferulic acid 
exhibited an excellent antioxidant activity with an 
inhibition of 90.4%, while an inhibition of 35.4% 
was recorded for p-hydroxyphenyl acetic acid. 
Ferulic acid also showed a mild antifungal activity 
at 500 µg/ml against A. niger with an IZD of                         
2 mm. p-Hydroxyphenyl acetic acid showed no 
antimicrobial activity. These results further confirm 
the potentials of endophytic fungi associated with 
Nigerian plants as source of bioactive compounds 
with pharmaceutical or industrial applications. 
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1. INTRODUCTION 
 
Endophytes are potential sources of biolo-
gically active natural products for exploitation in 
medicine, agriculture and industries. The discovery 
of novel drug molecules from endophytes is an 
important alternative to overcome the increasing 
threats of cancer and drug resistance by plant and 
human pathogens. 
Moringa oleifera, also known as moringa, 
drumstick tree, ben oil tree, benzoil tree, or horse-
radish tree, is the most widely cultivated species of 
the genus Moringa, the only genus in the family 
Moringaceae. M. oleifera is a fast-growing, drought-
resistant tree, widely cultivated in tropical and 
subtropical areas of the world, where its leaves and 
seed pods are used as vegetables and in herbal 
medicine [1]. 
M. oleifera leaves have been reported to be                 
a rich source of calcium, potassium, protein,                  
β-carotene, and natural antioxidants like vitamin C 
[2]. Traditionally, the roots, barks, pods, and leaves 
of M. oleifera are used in medicine for the treatment 
of a variety of human ailments such as inflamma-
tion, cardiovascular, hematological, hepatic and 
renal disorders [3, 4]. The plant is reported to show 
various biological activities, including antihyperten-
sive and cholesterol lowering [5-7], diuretic [8-9], 
antispasmodic [10-12], anti-ulcer [13], hepatopro-
tective [14], antibacterial and antifungal activities  
[15-18], and anticancer [19] activities. 
There are several reports of endophytic fungi 
associated with M. oleifera. Dhanalakshmi et al. 
[20] isolated endophytic Alternaria, Aspergillus, 
Bipolaris, Exosphiala, Nigrospora and Penicillium 
species from M. oleifera growing in the Yercaud 
hills of India. Secondary metabolites of some 
endophytic fungi of M. oleifera were evaluated for 
their antimicrobial and antioxidants properties [21-
23]. Zhao et al. [22] reported the isolation of four 
bioactive compounds (griseofulvin, dechlorogriseo-
fulvin, 8-dihydroramulosin, and mullein) from 
Nigrospora sp. associated with M. oleifera. 
Nigeria is rich with enormous and resourceful 
plant biodiversity, and these plants are hosts to 
millions of endophytic microbial communities that 
are can be explored as renewable source of natural 
products and present the opportunity to discover               
a plethora of compounds [24]. With the poten-     
tials reportedly possessed by the Nigerian plant              
M. oleifera and its associated endophytes, our study 
was aimed at investigating the secondary metabo-
lites of an endophytic fungus isolated from the 
leaves of M. oleifera growing in Anambra State, 
South-Eastern Nigeria. 
 
2. MATERIALS AND METHODS 
 
2.1. Isolation, identification and fermentation of 
endophytic fungus 
 
 Fresh healthy leaves of M. oleifera were 
collected from Agulu, Anambra State, South-Eastern 
Nigeria. The leaves were washed thoroughly in 
running tap water and cut into 1 cm fragments. The 
leaf fragments were surface-sterilized by immersion 
in 2% sodium hypochlorite solution for 2 min, and 
then in 70% ethanol for nearly 2 min, before a final 
rinse in sterile water for 5 min. The leaf fragments 
were then placed on Petri plates containing freshly 
prepared malt extract agar [(MEA) Oxoid, UK] 
supplemented with chloramphenicol. The Petri 
plates were incubated at 28oC, and fungal growths 
from the leaves were monitored. Hyphal tips from 
distinct colonies emerging from the leaves were sub-
cultured onto fresh MEA plates to obtain pure 
colonies. Identification of the isolated fungus was 
carried out based on its cultural, morphological and 
microscopic characteristics as described by Barnett 
and Hunter [25] and Ainsworth et al. [26]. Morpho-
logical identification, according to the standard 
taxonomic key, included colony diameter, texture, 
colour and the dimensions and morphology of 
hyphae and conidia. 
 
2.2. Fermentation, extraction, and isolation of 
metabolites 
 
 The endophytic fungus was subjected to solid 
state fermentation in a 1L Erlenmeyer flask con-
taining autoclaved rice medium (100 g of rice and 
200 ml of distilled water). The flask was inoculated 
with about 3 mm diameter agar blocks containing 
the fungus, and then incubated at 28°C for 21 days.  
At the completion of fermentation, the fungal 
secondary metabolites were extracted with EtOAc 
and the crude extract was concentrated under 
reduced pressure. Fractionation of the extract was 
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done using vacuum liquid chromatography on silica 
gel 60 (Merck, Germany) packed to a hard cake            
up to a height of 15 cm. Stepwise gradient elution 
was done using non-polar:moderately polar solvent 
system (DCM:MeOH). Fractions were further sepa-
rated on Sephadex LH-20 (Sigma-Aldrich, Ger-
many) using DCM:MeOH in the ratio of 1:1 (V/V) 
as mobile phase. Metabolites-containing fractions 
were further purified by semi-preparative HPLC. 
Analytical HPLC was used to identify important 
peaks in the extract and fractions, as well as to 
evaluate the purity of isolated compounds. 
 
2.3. Antimicrobial assay 
 
 Preliminary antimicrobial screening of the 
endophytic fungal extract was carried out using the 
agar well diffusion assay method described by 
Akpotu et al. [27]. A stock concentration of 4 mg/ml 
of the fungal extract was prepared by dissolving the 
extract in dimethyl sulphoxide [(DMSO) 100% v/v]. 
The stock solution was further diluted in a 2-fold 
serial dilution process to obtain 2, 1, and 0.5 mg/ml. 
Using sterile cotton swabs, standardized broth 
cultures of test bacterial isolates - S. aureus, B. sub-
tilis, S. pneumoniae, P. aeruginosa, E. coli, and            
K. pneumoniae, and fungal isolates - Aspergillus 
niger and Candida albicans were spread aseptically 
onto the surface of Mueller Hinton Agar [(MHA) 
Oxoid, UK] and Sabouraud Dextrose Agar [(SDA) 
Oxoid, UK] plates respectively. The culture plates 
were allowed to dry for about 5 min, and wells were 
made in the agar using a sterile 6 mm cork-borer. 
These wells were respectively filled with 20 μl of 
the different dilutions of the fungal extract and 
controls. Ciprofloxacin (5 μg/ml) and miconazole 
(50 µg/ml) were used as positive controls in the 
antibacterial and antifungal evaluations respectively; 
while DMSO (100% v/v) was used as the negative 
control. The culture plates were kept at room 
temperature for 1 h to allow the agents to diffuse 
into the agar medium. The MHA plates were then 
incubated at 37oC for 24 h, and the SDA plates were 
incubated at 25-27oC for 2-3 days. The plates were 
observed for inhibition zones diameters (IZDs) 
which were measured and recorded. The diameter      
of the well (6 mm) was deducted from the measu-
red values to get the actual IZDs. For each test 
isolate, this procedure was conducted in triplicate 
and the mean IZDs calculated.  
 
2.4. Cytotoxicity assay against ovarian cancer cell 
line A2780 
 
 The cytotoxic property of the fungal extract 
was determined using the MTT assay method 
described by Mueller et al. [28] and Engelke et al. 
[29]. Human ovarian cancer cells (A2780) were 
cultivated in RPMI-1640 medium supplemented 
with FBS (10%), streptomycin (120 μg/ml), and 
penicillin (120 U/ml), and incubated at 37°C in a 
humidified atmosphere containing 5% CO2. The 
cisplatin (cDDP)-resistant subclone A2780CisR was 
obtained by intermittent treatment of A2780 cells 
with cDDP for 24 weekly cycles. In the MTT assay, 
cells were plated into 96-well microtiter plates 
(about 9,000 cells/well) containing growth medium, 
and pre-incubated overnight. The cells were then 
incubated with appropriate concentrations of test 
sample for 72 h, followed by the addition of 25 μl  
of a solution of MTT to each well. With the 
formation of formazan crystals after about 10 min, 
the medium was removed. The formazan crystals 
were then dissolved in 75 μl DMSO, and using the 
BMG FLUOstar (BMG Labtechnologies, Offen-
burg, Germany), absorption was measured at 544 
nm (test wavelength) and 690 nm (reference wave-
length). Absorption of the reference wavelength was 
subtracted from that of the test wavelength. 
 
2.5. Antioxidant assay (DPPH free radical assay)  
 
 The free radical scavenging activity of the 
endophytic fungal extract was evaluated using the 
1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay method 
previously reported by Shen et al. [30], but with 
modification. Here, the percentage inhibition of the 
samples and positive control were determined at a 
concentration of 500 μg/ml from UV absorbance 
values recorded at 517 nm. A solution of 0.2 mM 
DPPH was prepared by adding 3.94 mg of DPPH 
(Sigma-Aldrich, Germany) in 50 ml of MeOH. A 
volume of 2 ml of the 0.2 mM DPPH solution was 
then added to 2 ml of the samples dissolved in 
MeOH (1 mg/ml, 1000 μg/ml). These final reaction 
mixtures resulted in a 2-fold dilution of the DPPH 
solution and samples, resulting in final concentration 
of 0.1 mM for the DPPH solution, and 500 μg/ml  
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for the samples. Quercetin was used as the positive 
control and 0.1 mM DPPH solution was used as 
blank. The mixtures were shaken vigorously and 
incubated at room temperature for 30 min, after 
which the absorbance (Abs) was measured at 517 
nm using a UV-VIS spectrophotometer. The free 
radical scavenging activity of the samples was 
calculated using the following formula: 
DPPH scavenging effect (% inhibition) = Abs of 
blank (A0) – Abs of sample (A1) X 100 / Abs of blank 
(A0) 
 
2.6. Bioassay of isolated compounds 
 
 The antimicrobial and antioxidant activities  
of the compounds isolated from the endophytic 
fungal extract were determined using the methods 
described above.  
 
2.7. General procedures 
 
 
1H-NMR spectra were recorded using Bruker 
300 and 600 spectrometers (Bruker BioSpin, Germa-
ny), and the spectra were referenced relative to the 
residual solvent signals. Mass spectra were recorded 
with a LC-MS HP1100 Agilent Finnigan LCQ Deca 
XP Thermoquest spectrometer (Thermo Electron, 
Germany). Analytical HPLC analysis was perfor-
med using a Dionex P580 system coupled to a 
P580A LPG pump and a photodiode array detector 
UVD340s (Dionex Softron, Germany). The sepa-
ration column (125 x 4 mm) was prefilled with 
Eurosphere-10 C18 (Knauer, Germany), and the 
following gradient solvent system was used: 0 min 
(10% MeOH), 5 min (10% MeOH), 35 min (100% 
MeOH), and 45 min (100% MeOH). Semi-prepa-
rative HPLC was performed using a Merck/Hitachi 
HPLC System (UV detector L-7400; pump L-7100), 
with a Eurosphere column (100 C18, 300 × 8 mm, 
Knauer, Germany). Gradient MeOH-H2O mixtures 
were used as mobile phase at a flow rate of 5.0 
ml/min. Vacuum liquid and open column chromato-
graphy were applied for fractionation using Silica 
gel 60 (70-230 mesh, Merck, Germany) and Sepha-
dex LH-20 (Sigma-Aldrich, Germany) respectively. 
TLC analysis on pre-coated silica gel plates (Kiesel-
gel 60 F254, 20×20 cm, 0.25 mm thick, Merck, 
Germany) was used to monitor and collect fractions 
under UV detection (Camag UV cabinet 4, Germa-
ny) at wave length of 254 and 366 nm. Distilled             
and spectral-grade solvents were used for column 
chromatography and spectroscopic measurements 
respectively. 
 
3. RESULTS 
 
 The results of the preliminary antimicrobial 
screening revealed that at a concentration range of 
1-4 mg/ml, crude extract of Aspergillus sp. showed 
antibacterial activity against one Gram positive 
bacteria B. subtilis and one Gram negative bacteria 
K. pneumoniae with inhibition zone diameters 
(IZDs) ranging from 1-5 mm. At concentrations of  
2 and 4 mg/ml, antifungal activity was recorded 
against C. albicans with IZDs of 3 and 5 mm 
respectively (Table 1).   
 
 
Table 1. Result of antimicrobial assay of Aspergillus sp. crude extract. 
Test organisms 
Mean Inhibition Zone Diameters (IZDs)(mm) 
Concentration (mg/ml) Positive control 
Ciprofloxacin (5 µg/mL) 
Negative control 
DMSO 4 2 1 0.5 
S. aureus 0 0 0 0 6 0 
B. subtilis 3 1 0 0 8 0 
S. pneumoniae 0 0 0 0 10 0 
P. aeruginosa 0 0 0 0 4 0 
E. coli 0 0 0 0 24 0 
K. pneumoniae 5 3 1 0 8 0 
 Miconazole (50 µg/ml) DMSO 
C. albicans 5 3 0 0 16 0 
A. niger 0 0 0 0 8 0 
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 In the DPPH antioxidant assay, at a concen-
tration of 500 µg/ml, the crude extract of Aspergillus 
sp. showed a good antioxidant activity with an 
inhibition of 72.1% (Table 2). The results of the 
cytotoxicity assay revealed that at a concentration of 
100 µg/ml, crude extract  of Aspergillus sp. showed 
an excellent cytotoxic activity against cisplatin-
sensitive ovarian cancer cell line A2780 (sens) and 
cisplatin-resistant ovarian cancer cell line A2780 
(cisR) with growth inhibitions of 105.1% and 
105.5% respectively (Table 3). At 10 µg/ml, the 
extract exhibited poor cytotoxic activity against the 
cell lines with growth inhibitions of 8.69% and 
3.04%, respectively. 
 The fungal crude extract was subjected to 
several chromatographic separations (vacuum liquid 
and open column chromatography) and semi-
preparative HPLC for the isolation of the bioactive 
compounds, as well as spectroscopic analyses            
(LC-MS and NMR), for structural elucidation of           
the isolated compounds. Two phenolic compounds 
(Compounds 1 and 2) were isolated (Figure 1). All 
these steps were monitored by subjecting the crude, 
fractions and isolated pure compounds to HPLC 
analysis. 
 
 
 
Compound 1 (C8H8O3. 152 g/mol) 
O
HO
OH
O
 
Compound 2 (C10H10O4. 194.18 g/mol) 
Figure 1. Phenolic compounds isolated from Aspergillus 
sp.: compounds 1 (p-hydroxyphenyl acetic acid) and                 
2 (ferulic acid). 
 
 
          Table 2. Antioxidant assay of Aspergillus sp. crude extract. 
Fungal extract Concentration (µg/ml) % Inhibition 
Aspergillus sp. crude extract 500 72.1 
Quercetin (control) 500 91.7 
 
 
          Table 3. Cytotoxicity assay of Aspergillus sp. extract on ovarian cancer cell lines. 
Ovarian cancer cell lines Concentration (µg/ml) Growth inhibition (%) 
2780 sens 100 105.1±1.41 
2780 CisR 100 105.5±2.06 
 
 
 The antimicrobial and antioxidant activities of 
the isolated compounds isolated from extract of 
Aspergillus sp. were also determined. Results of the 
bioassay carried out on the isolated compounds 
showed that p-hydroxyphenyl acetic acid exhibited a 
mild antioxidant activity at a concentration of 250 
µg/ml with an inhibition of 35.4% (Table 5). At a 
concentration of 500 µg/ml, the compound showed 
no antibacterial or antifungal activities (Table 4). 
Ferulic acid exhibited an excellent antioxidant 
activity at a concentration of 250 µg/ml with an 
inhibition of 90.4% higher than that recorded for the 
positive control Quercetin (83.9%) (Table 5). At a 
concentration of 500 µg/ml, the compound showed 
mild antifungal activities against A. niger with an 
IZD of 2 mm. No antibacterial activity was recorded 
(Table 4).  
 
3.1. Compound 1 
 
 The compound was isolated as an off-white 
crystalline solid. It exhibited U-maxima at λmax 
222.4 and 276.3 nm, which is characteristic of 
phenol derivatives. The LC-MS showed peak at             
m/z 151.1 [M-1]- in the negative mode, which is 
consistent with molar mass of 152 g/mol. The             
1H-NMR spectrum (500MHz, MeOH-d4) showed           
4 proton signals of the AA’BB’ coupling pattern at 
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δH 7.11 (d, 2H) and 6.75(d, 2H) assigned to H-2/6 
and H-3/5 respectively. An aliphatic proton signal  
at δH 3.50 (s, 2H), which integrated to 2 protons 
were assigned to H-2’A/A of the acetic acid moiety.                     
The compound was thus unequivocally identified           
as 2-(4-hydroxyphenyl) acetic acid, also known as             
p-hydroxyphenyl acetic acid or 4-hydroxyphenyl-
acetic acid. Spectroscopic data of the isolated 
compound is confirmed by the reports of Ohtani et 
al. [31] and Abe et al. [32]. 
 
 
Table 4. Antimicrobial assay of isolated compounds. 
 Mean Inhibition Zone Diameters (mm) 
Test organisms Compound 1 (p-HPA)  (500 µg/ml) 
Compound 2 (FA) 
(500 µg/ml) 
Ciprofloxacin 
(5 µg/ml) DMSO 
E. coli 0 0 5 0 
S. aureus 0 0 8 0 
S. typhi 0 0 7 0 
B. subtilis 0 0 8 0 
 0  Miconazole (50 µg/ml) DMSO 
A. niger 0 2 12 0 
C. albicans 0 0 14 0 
 
 
          Table 5. Antioxidant assay of the isolated compounds. 
Isolated compounds Concentration (µg/ml) % Inhibition 
Compound 1 (p-HPA) 250 35.4 
Compound 2 (FA) 250 90.4 
Quercetin (control) 250 83.9 
 
 
3.2. Compound 2 
 
 The compound was isolated as a light brown 
solid. It exhibited UV-maxima at λmax 217.0, 235.4 
and 323.1 nm. The UV also showed a shoulder 
around 300 nm. This UV features are characteristic 
of cinnamic acid derivatives. The LC-MS showed 
peaks at m/z 195.0 [M+1]+, 413.2 [2M+23]+, and 
177.1 [M-18]+ in the positive mode and 193.2          
[M-1]- in the negative mode. Analysis of these MS 
fragments indicated a molar mass of 194 g/mol. The 
1H-NMR spectrum (300 MHz, MeOH-d4) showed 
signals of 3 aromatic proton of the ABX coupling 
pattern at δH 7.18 (d, J=1.9, 1H), 7.07 (dd, J=2.0, 
8.2, 1H) and 6.81 (d, J=8.2, 1H) assigned to H-2, H-
6 and H-5 respectively. The 1H-NMR spectrum also 
showed two oleaginous proton signals at δH 7.60 (d, 
J=15.9, 1H) and 6.31 (d, J=15.9, 1H) assigned to H-
2’ and H-3’ respectively. The high coupling constant 
(15.9 Hz) was an indication that the two protons               
are in trans-configuration. The NMR also showed           
a methoxy signal at δH 3.90 (s, 3H) assigned to 
MeO-3. The compound was thus elucidated as                  
4-hydroxy-3-methoxycinnamic acid (ferulic acid). 
Spectroscopic data of the isolated compound is 
confirmed by the reports of Sajjadi et al. [33] and 
El-gizawy and Hussein [34]. 
 
4. DISCUSSION 
 
 The genus Aspergillus (Moniliaceae), with 
over 180 species, is a diverse genus with high eco-
nomic and social impact. Species occur worldwide 
in various habitats and they are known to spoil food, 
produce mycotoxins and are often reported as 
human and animal pathogens. The genus Aspergillus 
is one of the significant contributors to the 
secondary metabolites of fungal origin. They 
produce a broad range of structurally heterogeneous 
secondary metabolites and are known to be a rich 
source of alkaloids, terpenoids, xanthones, steroids, 
and polyketides, some of which showed antimicro-
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bial, antifouling, antifeedant, phytotoxic, or other 
interesting bioactivities [35-37]. Even after investi-
gations spanning over several decades, this genus 
nevertheless continues to yield metabolites with new 
structures and interesting biological activities [38]. 
 As in our study, there are reports of the 
isolation of endophytic Aspergillus species from           
M. oleifera [20, 23, 39, 40]. Endophytic Aspergillus 
species have also been isolated from several other 
plants including Cynodon dactylon [38], Gloriosa 
superba [41], Ipomoea batatas [42], Nymphoides 
peltata [43], Zingiber officinale [44], Carica papaya 
[45], and Loranthus micranthus [46]. 
 In our study, the crude EtOAc extract of 
Aspergillus sp. was tested for antimicrobial, cyto-
toxic and antioxidant activities. From the results of 
the bioassay, it was observed that Aspergillus sp. 
extract exhibited both antibacterial and antifungal 
activities (Table 1). The extract showed good 
antioxidant activity in the DPPH assay with an 
inhibition of 71.2% at a concentration of 500 µg/ml 
(Table 2). At a concentration of 100 µg/ml, the 
crude extract of Aspergillus sp. showed excellent 
cytotoxic activity against cisplatin-sensitive ovarian 
cancer cell line (2780 sens) and cisplatin-resistant 
ovarian cancer cell line (2780 CisR) with a growth 
inhibition of 105.1% and 105.5%, respectively 
(Table 3).  
 Chemical investigations of Aspergillus sp. 
crude extract yielded two phenolic compounds             
p-hydroxyphenyl acetic acid (p-HPA) and ferulic 
acid (FA). The compounds were characterized and 
screened for both antioxidant and antimicrobial 
activities. FA only showed mild antifungal activity 
against A. niger (at 500 µg/ml), but displayed an 
excellent antioxidant activity (at 250 µg/ml) with an 
inhibition of 90.4% higher than that recorded for  
the positive control quercetin (83.9%). p-HPA 
exhibited a mild antioxidant activity (at 250 µg/ml) 
with an inhibition of 35.4%. The compound showed 
no antimicrobial activity against any of the tested 
organisms (at 500 µg/ml) (Tables 4 and 5).  
 p-HPA is an important intermediate which is 
used for the synthesis of substances useful for 
pharmaceuticals. Many plants contain p-HPA and 
this compound is reported to be present in olive             
oil and beer [47, 48]. p-HPA has been isolated          
from several endophytic fungi including C. gloeo-
sporioides [49] and Oidiodendron sp. [31]. The 
nematicidal, antimicrobial and plant growth promo-
ting activities of p-HPA have been reported [31, 32, 
49, 50]. 
 FA is a ubiquitous natural phenolic phyto-
chemical present in plant seeds and leaves, and was 
first isolated from the plant Ferula foetida [51]. The 
compound is an enormously copious and almost 
ubiquitous phytochemical phenolic derivative of 
cinnamic acid, present in plant cell wall components 
as covalent side chains [52]. Collectively with 
dihydroferulic acid, FA acid is the component of 
lignocelluloses, where it confers rigidity to the cell 
wall by making the crosslink between polysaccha-
rides and lignin [51]. 
 There are some reports on the isolation of FA 
from fungi. Cheng et al. [53] also reported expres-
sion of the compound by the endophytic fungi 
Annulohypoxylon stygium. A significant yield of           
FA and other phenolic compounds was reported          
to be achieved when rice bran, containing low levels 
of the compound, was fermented by the fungus 
Rizhopus oryzae [54]. FA has also been reported as 
a secondary metabolite of endophytic Aspergillus 
species. Danagoudar et al. [44] reported the presence 
of FA together with other phenolic compounds in 
culture extract of A. austroafricanus isolated from 
Zingiber officinale rhizomes. 
 FA has been reported to possess several 
pharmacological activities including antioxidant [51, 
55, 56], anti-diabetic [51, 57, 58], antihypertensive 
[51, 59, 60], anticancer [33, 61, 62], anti-inflamma-
tory [33, 63], hepatoprotective [34], and antimi-
crobial [51, 63] activities. Other reported biological 
activities of FA include increase of sperm viability, 
modulation of enzyme activity, activation of trans-
criptional factors, gene expression, signal trans-
duction, metal chelation, anti-allergic, antithrom-
botic, antiviral, and vasodilatory activities [51]. 
 The excellent antioxidant activity showed by 
FA in this study confirms the reports of several 
authors on the antioxidant activity of the compound 
[51, 55, 56]. This compound may be responsible for 
the antioxidant activity showed by the fungal crude 
extract (Table 1). Because of these properties and its 
low toxicity, FA is now widely used in the food and 
cosmetic industries. It is used as the raw material for 
the production of vanillin and preservatives, and as a 
cross-linking agent for the preparation of food gels 
and edible films. It has been approved in some 
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countries as food additive to prevent lipid peroxi-
dation [33, 63, 64]. 
 The results of this study, together with other 
similar findings [24, 27, 45, 46, 65-71], confirms  
the many potentials possessed by Nigerian plants         
as hosts of endophytes that could be reservoirs                  
for excellent sources of pharmacologically active 
compounds.  
 
5. CONCLUSION 
 
 The fungus Aspergillus sp. from M. oleifera 
produced two phenolic acids p-hydroxyphenyl acetic 
acid and ferulic acid whose biological activities are 
well known, are diverse, and are being explored for 
their pharmaceutical and industrial importance. 
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